Cell Line Nucleofector® Kit V
Cell Line Nucleofector® Kit V
For efficient transfection of cell lines, e.g. HepG2, HL-60, Jurkat, K-562 , MCF7, SH-SY5Y, or THP-1, in the NucleofectorTM I/II/2b System
Do you need a quote right away? Add this product to your shopping cart, go to your cart and click on “Generate Quote”. Your quote will be available straight away to view, save online, and download in PDF format.
Product Overview
The Cell Line Nucleofector® Kit V is one of our five Nucleofector® Kits suited for transfecting cell lines in the Nucleofector® 2b System. This kit has been determined to be optimal for transfecting following cell types:
32D
3T3-L1
pre-ad
A20
A375
A7r5
AGS
ARPE-19
B16-F10
BA/F3 (DSMZ)
C2C12
C6
Capan-1
CHO [suspension]
CHO-S [suspension] (Life Technologies)
COS-1
HaCaT
HCT116
HEK293
HepG2
HL-60
HUV-EC-C
Jurkat
K-562 (DSMZ)
MCF7
MDA-MB-231
MDA-MB-468
NB-4 (DSMZ)
NCTC clone 929
Neuro-2a [N2a]
NG108-15
P19
PC-12
PC-3
Raji
Ramos
RAW 264.7
RBL-1
S49
Saos-2
Schneider‘s Drosophila Line 2
SH-SY5Y
SK-N-SH
SK-OV-3
SW480
T/C-28 a2
T/G
HA-VSMC
T-47D
THP-1
U-2 OS
Vero
The respective cell type-specific Optimized Protocol or recommendation is available under "Instructions" or in our knowledge database. In this Optimized Protocol the best Nucleofection conditions are indicated. In addition, we share our experience and knowledge for treatment of this cell type.
Request More Info
Benefits
- High transfection efficiencies in difficult-to-transfect cell lines
Applications
- Transfection of cell numbers in the range of 2 × 105 to 2 × 107 cells
- Low-throughput transfection in single cuvette format
Storage and Content
2.25 mL Nucleofector® Solution V
0.5 mL Supplement 1
30 µg pmaxGFPTM Vector (0.5 μg/μl in 10 mM Tris pH 8.0)
25 Aluminum cuvette (100 µL)
25 Single use pipettes
SDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.